DURECT Corporation and Charles River Laboratories: A Strategic Alliance Set to Revolutionize the Biopharmaceutical Industry. In a significant move within the biopharmaceutical industry, DURECT Corporation (DRRX) has entered into a co-marketing and collaboration agreement with Charles River Laboratories International, Inc. This alliance, announced on March 4, 2024, is set to jointly market and commercialize the ALZET Osmotic Pumps ...
$Durect(DRRX.US)$Durect Corporation Has Entered Into A Co-marketing And Collaboration Agreement With Charles River Laboratories For The Alzet Osmotic Pumps Portfolio And Associated Product Line In The US And Canada
$Durect(DRRX.US)$Durect's Topline Results From Phase 2B AHFIRM Trial Of Larsucosterol In Alcohol-Associated Hepatitis Did Not Achieve Statistical Significance For Either Dose On The Primary Endpoint Of Mortality Or Transplant At 90 Days
Durect股票討論區
加載中...
加載中...
In a significant move within the biopharmaceutical industry, DURECT Corporation (DRRX) has entered into a co-marketing and collaboration agreement with Charles River Laboratories International, Inc. This alliance, announced on March 4, 2024, is set to jointly market and commercialize the ALZET Osmotic Pumps ...
暫無評論